These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2809701)

  • 1. In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1 Suppl 2():36-40. PubMed ID: 2809701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Studies of Tigemonam: a Comparison of the Minimum Inhibitory and Minimum Bactericidal Concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1(sup2):36-40. PubMed ID: 27416148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity in vitro of tigemonam, a new oral monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of tigemonam against multiresistant nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1 Suppl 2():32-5. PubMed ID: 2809700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of tigemonam against urinary tract pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1 Suppl 2():13-21. PubMed ID: 2809698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of tigemonam, alone and in combination with gentamicin.
    Shah PM; Gänger-Farshid G; Mulert R; Stille W
    J Chemother; 1989 May; 1 Suppl 2():45-8. PubMed ID: 2809703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro effect of ceftriaxone on hospital bacteria. Line of regression and critical values].
    Cluzel M; Chanal M; Sirot D; Sirot J; Cluzel R
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):473-6. PubMed ID: 3937122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigemonam, an oral monobactam.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1988 Jan; 32(1):84-91. PubMed ID: 3279906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro activity of tigemonam: a comparison with other antimicrobial agents.
    Andrews JM; Wise R
    J Chemother; 1989 May; 1 Suppl 2():5-12. PubMed ID: 2509645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial Activity of Tigemonam Dicholate (SQ 30836) and Interaction With Beta-Lactamases of Gram-Negative Bacteria.
    Raimondi A; Cocuzza CE
    J Chemother; 1989 May; 1(sup2):13-21. PubMed ID: 27416144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth curve patterns of Escherichia coli, Serratia marcescens, and Proteus vulgaris submitted to different tigemonam concentrations.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F
    J Chemother; 1989 May; 1 Suppl 2():49-53. PubMed ID: 2681561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Activity of Tigemonam Against Multiresistant Nosocomial Enterobacteriaceae.
    Giamarellou H; Pephanis A; Grammatikou M; Avlamis A; Papoulias G
    J Chemother; 1989 May; 1(sup2):32-35. PubMed ID: 27416147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
    Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
    Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multicenter study of the antibacterial activity of a new cephalosporin: CM 40874].
    Duval J; Soussy CJ; Deforges L; Brun Y; Coulet M; Forey F; Thabaut A; Meyran M; Acar JF; Kitzis MD
    Pathol Biol (Paris); 1984 May; 32(5):331-4. PubMed ID: 6547524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial Activity In Vitro of Tigemonam, a New Oral Monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1(sup2):41-44. PubMed ID: 27416149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antibacterial activity of cefmenoxime (SCE 1365)].
    Brun Y; Forey F; Coulet M; Fleurette J; Bryskier A
    Pathol Biol (Paris); 1983 May; 31(5):343-6. PubMed ID: 6312394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.